Company Overview:
lyell immunopharma inc - AOMR
AOMR Key Data
| Open $8.25 | Day Range 8.17 - 8.25 |
| 52 Week Range 7.96 - 9.93 | Market Cap $192.92M |
| Shares Outstanding 23.21M | Public Float 17.26M |
| Beta 1.19 | Rev. Per Employee N/A |
| P/E Ratio 11.18 | EPS $0.78 |
| Yield 1,555.29% | Dividend $0.32 |
| EX-DIVIDEND DATE Aug 21, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 148.00K |
|
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | | Average Target Price | 10.55 |
| Number of Ratings | 6 | | Current Quarters Estimate | 0.32 |
| FY Report Date | 09 / 2026 | | Current Year's Estimate | 1.241 |
| Last Quarter’s Earnings | 0.371 | | Median PE on CY Estimate | N/A |
| Year Ago Earnings | 0.59 | | Next Fiscal Year Estimate | 1.413 |
| | | Median PE on Next FY Estimate | N/A |
Earnings Per Share
|
This Quarter
|
Next Quarter
|
This Fiscal
|
Next Fiscal
|
| # of Estimates | 6 | 6 | 6 | 6 |
| Mean Estimate | 0.32 | 0.34 | 1.24 | 1.41 |
| High Estimates | 0.36 | 0.37 | 1.30 | 1.50 |
| Low Estimate | 0.27 | 0.31 | 1.15 | 1.30 |
| Coefficient of Variance | 10.79 | 6.66 | 4.30 | 4.74 |
Analysts Recommendations
|
Current
|
1 Month Ago
|
3 Months Ago
|
| BUY |
4
|
4
|
4
|
| OVERWEIGHT |
0
|
0
|
0
|
| HOLD |
2
|
2
|
2
|
| UNDERWEIGHT |
0
|
0
|
0
|
| SELL |
0
|
0
|
0
|
| MEAN |
Overweight
|
Overweight
|
Overweight
|
Insider Actions for Lyell Immunopharma Inc - AOMR
| Date | Name | Shares | Transaction | Value |
|
May 27, 2026
| Wesley Denny Minami Director |
80,318
| Open market or private purchase of non-derivative security Non-derivative transaction at $8.15 per share |
654,591.70
|